A quartic expression of W in terms of solvent solubility parameter was found for predicting the mole fraction solubility of satranidazole in the studied mixtures. The method has potential usefulness in preformulation and formulation studies during which solubility prediction is important for drug design.
Short Communication
Extended Hildebrand solubility approach is applied to predict the solubility of satranidazole in mixtures of water and N,N-dimethylformamide (DMF). DMF is a very interesting cosolvent to study the interrelation between drug solubility and medium polarity because it is aprotic and completely miscible with water [1] . Water-DMF mixtures are strongly non ideal and can act in the solute-solvation process via hydrophobic interactions and preferential solvation [2, 3] . In terms of polarity, water-DMF mixtures cover a wide range of Hildebrand solubility parameters from 12.1 (pure DMF) to 23.4 (pure water) [4, 5] .
The extended Hildebrand solubility approach enables us to predict the solubility of semipolar crystalline drugs in irregular solutions involving self-association and hydrogen bonding in pure solvents or in solvent blends. The key relationship may be written as [6, 7] , 
where K is a proportionality constant [8] .
Interaction energy (W) values were evaluated as a power series in d 1 utilizing mixed solvents by polynomial regression [9] [10] [11] . By using these polynomial fits, the mole fraction solubility of solutes may be predicted that is in good agreement with the experimental values. This procedure may be applied for calculating solubilities of missing data by interpolation. When the solvent studied is a mixed one, there are a series of parameters to be calculated such as: the solubility parameter, the volume fraction and the mean molar volume of mixed solvents.
The solubility parameter (d 1 ) for the mixture of two solvents DMF and water, W, is averaged in terms of volume fractions using the expression [12] ,
where Ф 1 =Ф DMF +Ф W is the total volume fraction of two solvents which can be calculated from [13] ,
where X 2 is the mole fraction solubility of the solute in the mixed solvent and V 1 is the molar volume of the binary solvent. For each mixed solvent composed of water and DMF in various proportions [14] :
Here, X i and M i are the mole fraction and the molecular weight of the particular solvent in the mixture, respectively and d 1 is the density of the solvent mixture at the experimental temperature.
Satranidazole, 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone, is one of the large series of nitroimidazoles with a potent antiprotozoal activity against E. hystolytica, T. vaginalis and Giardia. Satranidazole is not official in IP, USP and BP till date. Though the molecule is found to be effective against these microorganisms, its therapeutic efficacy is hindered due to its poor aqueous solubility (0.01 mg/ml). The poor aqueous solubility and wettability of satranidazole give rise to difficulties in pharmaceutical formulations meant for oral or parenteral use, which may lead to variation in bioavailability [15] [16] [17] [18] .
As such, no solubility reports are found for its estimation and prediction by any of the method till date. Hence, the aim of this communication is to report the solubility behaviour of satranidazole in individual solvents (water and DMF) and different concentrations of water-DMF mixtures, predict it theoretically by applying the Extended Hildebrand Solubility Approach.
Satranidazole, obtained as gift sample from Erika Pharmaceuticals, Mumbai, India, was purified by recrystallization process. The solvent used for recrystallization of satranidazole was acetone. DMF and acetone both were obtained as gift samples from Qualigens Fine Chemicals, Mumbai, India.
Throughout the study, double distilled water was used for experimental purpose. All chemicals and reagents used in the study were of analytical grade and used as such. Preliminary studies showed that this time period was sufficient to ensure saturation at 25° [ 19] .
After equilibration, the solution was microfiltered (0.45 µm) and the filtrate was then diluted with double distilled water to carry out the spectrophotometric determination at the maximum wavelength of absorption of satranidazole (λ max -319.80 nm). Calibration graphs of satranidazole in each solvent blend were previously established with correlation coefficients greater than 0.9978. The working concentration range was from 10 to 50 µg/ ml satranidazole. The densities of the blends as well as the filtrates of saturated solutions were determined by using 25-ml specific gravity bottle at 25°. Once the densities of solutions are known, the solubilities can be expressed in mole fraction scale.
The molar volume (V 2 ) and the solubility parameter of satranidazole were previously estimated by using the Fedor's group contribution method [20, 21] giving 235.6 cm 3 /mol and 11.3928 (cal/cm 3 ) 0.5 . The ideal solubility of satranidazole was calculated by using the equation [22] ,
where, ΔS f is the entropy of fusion of the crystalline drug molecule at its melting point T 0 and T is the temperature in Kelvin at which the solubility was determined. The value of ΔS f was evaluated by [23] , Observed solubility data were then subjected to the evaluation of interaction energy. The interaction term W can be calculated from Eq.1 at each experimental point (X 2 , d 1 ). The results are also presented in Table 1 . Experimental values of interaction energy (W obs ) were regressed against solubility parameter to obtain W cal ( fig. 2) , which was then used to back-calculate the mole fraction solubility (X 2cal ). A mathematical model is proposed for individual system as fourth power polynomial. The W values may also be expanded in a power series of d 1 from fourth degree polynomial regression.
In our case, the following fit was obtained:
If we insert this equality in Eqn. 1, we can predict the solubility of satranidazole. The back-calculated logarithmic solubilities, log X 2cal are recorded in Table 2 , together with the experimental values of log X 2 and their differences. The plot of log X 2cal against log X 2obs gives a straight line passing through the origin with very high degree of correlation coefficient (R 2 ) 0.9912 and negligible intercept (0.00009) equal to zero as shown in fig. 3 .
A careful scrutiny of the behaviour of the solutions of satranidazole in water-DMF mixtures may be Thus, in water-rich mixtures (0-0.5) there seems to be some kind of association between satranidazole and the solvent mixture according to W>d 1 d 2 . This finding could be explained considering the hydrophobic hydration (HH). HH is featured by an enhanced hydrogen bonding between water molecules in the neighbourhood of nonpolar groups in water. When adding DMF, HH breaks down. The endothermic shift of the enthalpies of solution upon small additions of aprotic cosolvent to water is known to appear for hydrophobic solutes like satranidazole.
Conversely, in water poor mixtures (0.6-1.0) self-association of solvent, solute or both is not obtained because W is still far greater than d 1 d 2 . This behaviour may remain as such in rich DMF blends, and therefore, the corresponding satranidazole solubilities are still higher than regular one.
The extended Hildebrand approach applied to the solubility data of satranidazole in water-DMF mixtures leads to an expansion of the W interaction term as a fourth degree power series in d 1 which reproduces the satranidazole solubility within the accuracy ordinarily achieved in such measurements. The procedure can be used to predict the solubility of satranidazole in pure water or DMF and in any water-DMF mixtures. 
